rpact: Confirmatory Adaptive Clinical Trial Design and Analysis

This R markdown file provides examples for designing trials with survival endpoints with rpact. These examples are not intended to replace the official rpact documentation and help pages but rather to supplement them. They also only cover a selection of all rpact features.

General convention: In rpact, arguments containing the index “2” always refer to the control group, “1” refer to the intervention group, and treatment effects compare treatment versus control.

2 Overview of relevant rpact functions

Sample size calculation for a group-sequential trial with a survival endpoints is performed in two steps:

  1. Define the (abstract) group-sequential design using the function getDesignGroupSequential. For details regarding this step, see the R markdown file “Defining group-sequential boundaries with rpact”. This step can be omitted if the trial has no interim analyses.

  2. Calculate sample size for the survival endpoint by feeding the abstract design into function getSampleSizeSurvival. This step is described in detail below.

Other relevant rpact functions for survival are:

  • getPowerSurvival: This function is the analogue to getSampleSizeSurvival for the calculation of power rather than sample size.
  • getEventProbabilities: Calculates the probability of an event depending on follow-up time. This is useful for aligning interim analyses for different time-to-event endpoints.
  • getSimulationSurvival: This function simulates group-sequential trials. For example, it allows to assess the power of trials with delayed treatment effects or to assess the data-dependent variability of the timing of interim analyses even if the protocol assumptions are perfectly fulfilled. It also allows to simulate hypothetical datasets for trials stopped early.

This document describes all functions mentioned above except for trial simulation (getSimulationSurvival) which is described in the document “Simulation-based design of group-sequential trials with a survival endpoint with rpact”.

However, before describing the functions themselves, the document describes how survival functions, drop-out, and accrual can be specified in rpact which is required for all of these functions.

3 Specifying survival distributions in rpact

rpact allows to specify survival distributions with exponential, piecewise exponential, and Weibull distributions. Exponential and piecewise exponential distributions are described below.

Weibull distributions are specified in the same way as exponential distributions except that an additional scale parameter kappa needs to be provided which is 1 for the exponential distribution. Note that the parameters shape and scale in the standard R functions for the Weibull distribution in the stats-library (such as dweibull) are equivalent to kappa and 1/lambda, respectively, in rpact.

3.1 Exponential survival distributions

3.1.1 Event probability at a specific time point known

  • The time point is given by argument eventTime.
  • The probability of an event (i.e. 1 minus survival function) in the control group is given by argument pi2.
  • The probability of an event in the intervention arm can either be provided explicitly through argument pi1 or, alternatively, implicitly by specifying the target hazard ratio hazardRatio.

Example: If the intervention is expected to improve survival at 24 months from 70% to 80%, this would be expressed through arguments eventTime=24, pi2=0.3, pi1=0.2.

3.1.2 Exponential parameter \(\lambda\) known

  • The constant hazard function in the control arm can be provided as argument lambda2.
  • The hazard in the intervention arm can either be provided explicitly through the argument lambda1 or, alternatively, implicitly by specifying the target hazard ratio hazardRatio.

3.1.3 Median survival known

Medians cannot be specified directly. However, one can exploit that the hazard rate \(\lambda\) of the exponential distribution is equal to \(\lambda=\log(2)/\text{median}\).

Example: If the intervention is expected to improve the median survival from 60 to 75 months, this would be expressed through the arguments lambda2=log(2)/60, lambda1=log(2)/75. Alternatively, it could be specified via lambda2=log(2)/60, hazardRatio=0.8 (as the hazard ratio is 60/75=0.8).

3.2 Weibull

Weibull distributions are specified in the same way as exponential distributions except that an additional scale parameter kappa needs to be provided which is 1 for the exponential distribution.

3.3 Piecewise exponential survival

3.3.1 Piecewise constant hazard rate \(\lambda\) in each interval known

Example: If the survival function in the control arm is assumed to be 0.03 (events/time-unit of follow-up) for the first 6 months, 0.06 for months 6-12, and 0.02 from month 12 onwards, this can be specified using the argument piecewiseSurvivalTime as follows:

piecewiseSurvivalTime=list("0 - <6" =0.03,
                           "6 - <12"=0.06,
                           ">=12"   =0.02)

Alternatively, the same distribution can be specified by giving the start times of each interval as argument piecewiseSurvivalTime and the actual hazard rate in that interval as argument lambda2. I.e., the relevant arguments for this example would be:

piecewiseSurvivalTime=c(0,6,12), lambda2=c(0.03,0.06,0.02)

For the intervention arm, one could either explicitly specify the hazard rate in the same time intervals through the argument lambda1 or, more conveniently, specify the survival function in the intervention arm indirectly via the target hazard ratio (argument hazardRatio).

Note: The sample size calculation functions discussed in this document assume that the proportional hazards assumption holds, i.e., that lambda1 and lambda2 are proportional if both are provided. Otherwise, the function call to getSampleSizeSurvival gives an error. For situations with non-proportional hazards, please see the separate document which discusses the simulation tool using the function getSimulationSurvival.

3.3.2 Survival function at different time points known

Piecewise exponential distribution are useful to approximate survival functions. In principle, it is possible to approximate any distribution function well with a piecewise exponential distribution if suitably narrow intervals are chosen.

Assume that the survival function is \(S(t_1)\) at time \(t_1\) and \(S(t_2)\) at time \(t_2\) with \(t_2>t_1\) and that the hazard rate in the interval \([t_1,t_2]\) is constant. Then, the hazard rate in the interval can be derived as \((\log(S(t_1))-\log(S(t_2)))/(t_2-t_1)\).

Example: Assume that it is known that the survival function is 1, 0.9, 0.7, and 0.5 at months 0, 12, 24, 48 in the control arm. Then, an interpolating piecewise exponential distribution can be derived as follows:

## [1] 0.008780043 0.020942869 0.014019677 0.014019677

4 Specifying dropout in rpact

rpact models dropout with an independent exponentially distributed variable. Dropout is specified by giving the probability of dropout at a specific time point. For example, an annual (12-monthly) dropout probability of 5% in both treatment arms can be specified through the following arguments:

dropoutRate1 = 0.05, dropoutRate2 = 0.05, dropoutTime = 12

5 Specifying accrual in rpact

rpact allows to specify arbitrarily complex recruitment scenarios. Some examples are provided below.

5.1 Absolute accrual intensity and accrual duration known

Example 1: A constant accrual intensity of 24 subjects/months over 30 months (i.e., a maximum sample size of 24*30=720 subjects) can be specified through the arguments below:

accrualTime = c(0,30), accrualIntensity=24

Example 2: A flexible accrual intensity of 20 subjects/months in the first 6 months, 25 subjects/months for months 6-12, and 30 subjects per month for months 12-24 can be specified through either of the two equivalent options below:

Option 1: List-based definition:

accrualTime = list("0 - <6"  = 20,
                   "6 - <12" = 25,
                   "12- <24" = 30)

Option 2: Vector-based definition (note that the length of the accrualTime vector is 1 larger than the length of the accrualIntensity as the end time of the accrual period is also included):

accrualTime = c(0,6,12,24), accrualIntensity=c(20,25,30)

5.2 Absolute accrual intensity known, accrual duration unknown

Example 1: A constant accrual intensity of 24 subjects/months with unspecified end of recruitment is specified through the arguments below:

accrualTime = 0, accrualIntensity=24 
# Note: accrualTime is the start time of accrual here which must be explicitly set to 0

Example 2: A flexible accrual intensity of 20 subjects/months in the first 6 months, 25 subjects/months from month 6-12, and 30 subjects thereafter can be specified through either of the two equivalent options below:

Option 1: List-based definition:

accrualTime = list("0 - <6"  = 20,
                   "6 - <12" = 25,
                   ">=12"    = 30)

Option 2: Vector-based definition (note that the length of the accrualTime vector is equal to the length of the accrualIntensity vector as only the start time of the last accrual intensity is provided):

accrualTime = c(0,6,12), accrualIntensity=c(20,25,30)

6 Sample size calculation for superiority trials without interim analyses

Given the specification of the survival distributions, drop-out and accrual as described above, sample size calculations can be readily performed in rpact using the function getSampleSizeSurvival. Importantly, in survival trials, the number of events (and not the sample size) determines the power of the trial. Hence, the choice of the sample size to reach this target number of events is based on study-specific trade-offs between the costs per recruited patient, study duration, and desired minimal follow-up duration.

In practice, a range of sample sizes need to be explored manually or via suitable graphs to find an optimal trade off. Given a plausible absolute accrual intensity (usually provided by operations), a simple approach in rpact is to use one or both of the two options below:

  1. Perform the calculation by trying multiple maximum sample sizes (argument maxNumberOfSubjects).
  2. It often makes sense to require a minimal follow-up time (argument followUpTime) for all patients in the trial at the time of the analysis. In this case, rpact automatically determines the maximum sample size.

6.1 Example - exponential survival, flexible accrual intensity, no interim analyses

  • Exponential PFS with a median PFS of 60 months in control (lambda2=log(2)/60) and a target hazard ratio of 0.74 (hazardRatio=0.74).
  • Log-rank test at the two-sided 5%-significance level (sided=2, alpha=0.05), power 80% (beta=0.2).
  • Annual drop-out of 2.5% in both arms (dropoutRate1 = 0.025, dropoutRate2 = 0.025, dropoutTime = 12).
  • Recruitment is 42 patients/month from month 6 onwards after linear ramp up. (accrualTime = c(0,1,2,3,4,5,6), accrualIntensity=c(6,12,18,24,30,36,42))
  • Randomization ratio 1:1 (allocationRatioPlanned=1). This is the default and is thus not explicitly set in the function call below.
  • Two sample size choices will be initially explored:
    • A fixed total sample size of 1200 (maxNumberOfSubjects = 1200).
    • Alternatively, the total sample size will be implicitly determined by specifying that every subject must have a minimal follow-up duration of at 12 months at the time of the analysis (followUpTime=12).

Based on this, the required number of events and timing of interim analyses for the fixed total sample size of 1200 can be determined as follows:

## Design plan parameters and output for survival data:
## 
## Design parameters:
##   Significance level                           : 0.0500 
##   Type II error rate                           : 0.2 
##   Test                                         : two-sided 
## 
## User defined parameters:
##   Lambda (2)                                   : 0.0116 
##   Hazard ratio                                 : 0.740 
##   Maximum number of subjects                   : 1200.0 
##   Event time                                   : 12 
##   Accrual time                                 : 1.00, 2.00, 3.00, 4.00, 5.00, 6.00, 31.57 
##   Accrual intensity                            : 6.0, 12.0, 18.0, 24.0, 30.0, 36.0, 42.0 
##   Drop-out rate (1)                            : 0.025 
##   Drop-out rate (2)                            : 0.025 
## 
## Default parameters:
##   Type of computation                          : Schoenfeld 
##   Theta H0                                     : 1 
##   Planned allocation ratio                     : 1 
##   Piecewise survival times                     : 0.00 
##   Drop-out time                                : 12.00 
## 
## Sample size and output:
##   Direction upper                              : FALSE 
##   pi (1)                                       : 0.0975 
##   pi (2)                                       : 0.129 
##   Median (1)                                   : 81.1 
##   Median (2)                                   : 60.0 
##   Lambda (1)                                   : 0.00855 
##   Number of events                             : 346.3 
##   Total accrual time                           : 31.57 
##   Follow up time                               : 21.54 
##   Calculate follow up time                     : TRUE 
##   Number of subjects fixed                     : 1200.0 
##   Number of subjects fixed (1)                 : 600.0 
##   Number of subjects fixed (2)                 : 600.0 
##   Analysis times                               : 53.11 
##   Study duration                               : 53.11 
##   Lower critical values (effect scale)         : 1.234 
##   Upper critical values (effect scale)         : 0.810 
##   Local two-sided significance levels          : 0.0500 
## 
## Legend:
##   (i): values of treatment arm i

Thus, the required number of events is 347 and the MDD corresponds to an observed HR of .The 1200 subjects will be recruited over 31.57 months and the total study duration is 53.11 months. The user could now vary maxNumberSubject to further optimize the trade-off between sample size and study duration.

Alternatively, specifying a minimum follow-up duration of 12 months leads to the following result:

## Design plan parameters and output for survival data:
## 
## Design parameters:
##   Significance level                           : 0.0500 
##   Type II error rate                           : 0.2 
##   Test                                         : two-sided 
## 
## User defined parameters:
##   Lambda (2)                                   : 0.0116 
##   Hazard ratio                                 : 0.740 
##   Event time                                   : 12 
##   Accrual time                                 : 1.00, 2.00, 3.00, 4.00, 5.00, 6.00, 37.13 
##   Accrual intensity                            : 6.0, 12.0, 18.0, 24.0, 30.0, 36.0, 42.0 
##   Follow up time                               : 12.00 
##   Drop-out rate (1)                            : 0.025 
##   Drop-out rate (2)                            : 0.025 
## 
## Default parameters:
##   Type of computation                          : Schoenfeld 
##   Theta H0                                     : 1 
##   Planned allocation ratio                     : 1 
##   Piecewise survival times                     : 0.00 
##   Drop-out time                                : 12.00 
## 
## Sample size and output:
##   Direction upper                              : FALSE 
##   pi (1)                                       : 0.0975 
##   pi (2)                                       : 0.129 
##   Median (1)                                   : 81.1 
##   Median (2)                                   : 60.0 
##   Lambda (1)                                   : 0.00855 
##   Maximum number of subjects                   : 1433.7 
##   Number of events                             : 346.3 
##   Total accrual time                           : 37.13 
##   Calculate follow up time                     : TRUE 
##   Number of subjects fixed                     : 1433.7 
##   Number of subjects fixed (1)                 : 716.8 
##   Number of subjects fixed (2)                 : 716.8 
##   Analysis times                               : 49.13 
##   Study duration                               : 49.13 
##   Lower critical values (effect scale)         : 1.234 
##   Upper critical values (effect scale)         : 0.810 
##   Local two-sided significance levels          : 0.0500 
## 
## Legend:
##   (i): values of treatment arm i

This specification leads to a higher sample size of 1434 subjects which will be recruited over 37.13 months and the total study duration is 49.13 months.

To further explore the possible trade-offs, one could visualize recruitment and study durations for a range of sample sizes as illustrated in the code below:

7 Sample size calculation for non-inferiority trials without interim analyses

Sample size calculation proceeds in the same fashion as for superiority trials except that the role of the null and the alternative hypothesis are reversed. I.e. in this case, the non-inferiority margin \(\Delta\) corresponds to the treatment effect under the null hypothesis (thetaH0). Testing for non-inferiority trials is always one-sided.

In the example code below, we assume that the non-inferiority margin corresponds to a 20% increase of the hazard function and that “in reality”, i.e. under the alternative hypothesis, the survival functions in the two groups are equal. In this case, the “null hypothesis” is thetaH0=1.2 versus the “alternative” hazardRatio=1. For illustration, all other assumptions were chosen as per the sample size calculations for superiority trials above.

## Design plan parameters and output for survival data:
## 
## Design parameters:
##   Significance level                           : 0.0250 
##   Type II error rate                           : 0.2 
##   Test                                         : one-sided 
## 
## User defined parameters:
##   Theta H0                                     : 1.2 
##   Lambda (2)                                   : 0.0116 
##   Hazard ratio                                 : 1.000 
##   Event time                                   : 12 
##   Accrual time                                 : 1.00, 2.00, 3.00, 4.00, 5.00, 6.00, 65.12 
##   Accrual intensity                            : 6.0, 12.0, 18.0, 24.0, 30.0, 36.0, 42.0 
##   Follow up time                               : 12.00 
##   Drop-out rate (1)                            : 0.025 
##   Drop-out rate (2)                            : 0.025 
## 
## Default parameters:
##   Type of computation                          : Schoenfeld 
##   Planned allocation ratio                     : 1 
##   Piecewise survival times                     : 0.00 
##   Drop-out time                                : 12.00 
## 
## Sample size and output:
##   Direction upper                              : FALSE 
##   pi (1)                                       : 0.129 
##   pi (2)                                       : 0.129 
##   Median (1)                                   : 60.0 
##   Median (2)                                   : 60.0 
##   Lambda (1)                                   : 0.0116 
##   Maximum number of subjects                   : 2609.2 
##   Number of events                             : 944.5 
##   Total accrual time                           : 65.12 
##   Calculate follow up time                     : TRUE 
##   Number of subjects fixed                     : 2609.2 
##   Number of subjects fixed (1)                 : 1304.6 
##   Number of subjects fixed (2)                 : 1304.6 
##   Analysis times                               : 77.12 
##   Study duration                               : 77.12 
##   Critical values (effect scale)               : 1.056 
##   Local one-sided significance levels          : 0.0250 
## 
## Legend:
##   (i): values of treatment arm i

In this example, the required number of events is 945. The specification above leads to a sample size of 2610 subjects recruited over 65.12 months and an expected total study duration of 77.12 months.

8 Sample size calculation for trials with interim analyses

Calculations can be performed as for trials without interim analyses except that the group-sequential design needs to be specified using getDesignGroupSequential before calling getSampleSizeSurvival. For details regarding the specification of the group-sequential design, see the R markdown file “Defining group-sequential boundaries with rpact”.

In general, rpact supports both one-sided and two-sided group-sequential designs. However, if futility boundaries are specified, only one-sided tests are permitted. For simplicity, it is often preferred to use one-sided tests for group-sequential designs (typically with \(\alpha=0.025\)).

One additional consideration for phase III trials with efficacy interim analyses is that they should only be performed at time-points when the data is sufficiently mature to allow for a potential filing. For example, it is often sensible to perform efficacy interim analyses only after all subjects have been recruited. This aspect can be further explored by looking at simulated data for (hypothetical) trials that would have stopped at the interim analysis. This can easily be implemented using the simulation tool in rpact and we refer to the R markdown document “Simulation-based design of group-sequential trials with a survival endpoint with rpact” for further details.

8.1 Example - piece-wise exponential survival, constant accrual intensity, group-sequential design

  • 1:1 randomized.
  • 80% power at the one-sided 2.5% significance level.
  • Efficacy interim analyses at 50% and 75% of total information using an O’Brien&Fleming type \(\alpha\)-spending function, no futility interim analyses.
  • Target HR for primary endpoint (PFS) is 0.75.
  • PFS in the control arm follows a piece-wise exponential distribution, with the hazard rate h(t) estimated using historical controls as follows:
    • h(t) = 0.025 for t between 0 and 6 months,
    • h(t) = 0.04 for t between 6 and 9 months,
    • h(t) = 0.015 for t between 9 and 15 months,
    • h(t) = 0.01 for t between 15 and 21 months,
    • h(t) = 0.007 for t beyond 21 months.
  • An annual dropout probability of 5%.
  • Recruitment of 42 patients/month up to a maximum of 1000 subjects.

8.1.1 Sample size calculation

The group-sequential design (including type I and II error) can be specified as follows:

The piecewise exponential survival is defined as described above:

Now, the sample size calculation can be performed:

The sample size result can be summarized by displaying the default rpact output:

## Design plan parameters and output for survival data:
## 
## Design parameters:
##   Significance level                           : 0.0250 
##   Type II error rate                           : 0.2 
##   Test                                         : one-sided 
## 
## User defined parameters:
##   Lambda (2)                                   : 0.025, 0.040, 0.015, 0.010, 0.007 
##   Hazard ratio                                 : 0.750 
##   Accrual time                                 : 23.81 
##   Accrual intensity                            : 42.0 
##   Piecewise survival times                     : 0.00, 6.00, 9.00, 15.00, 21.00 
##   Drop-out rate (1)                            : 0.050 
##   Drop-out rate (2)                            : 0.050 
## 
## Default parameters:
##   Type of computation                          : Schoenfeld 
##   Theta H0                                     : 1 
##   Planned allocation ratio                     : 1 
##   Event time                                   : 12 
##   Drop-out time                                : 12.00 
## 
## Sample size and output:
##   Direction upper                              : FALSE 
##   Lambda (1)                                   : 0.01875, 0.03000, 0.01125, 0.00750, 0.00525 
##   Maximum number of subjects                   : 1000.0 
##   Maximum number of subjects (1)               : 500.0 
##   Maximum number of subjects (2)               : 500.0 
##   Maximum number of events                     : 386.8 
##   Follow up time                               : 36.19 
##   Calculate follow up time                     : TRUE 
##   Information rates [1]                        : 0.500 
##   Information rates [2]                        : 0.750 
##   Information rates [3]                        : 1.000 
##   Analysis times [1]                           : 23.17 
##   Analysis times [2]                           : 33.28 
##   Analysis times [3]                           : 60.00 
##   Expected study duration under H1             : 43.87 
##   Maximal study duration                       : 60.00 
##   Number of events by stage [1]                : 193.4 
##   Number of events by stage [2]                : 290.1 
##   Number of events by stage [3]                : 386.8 
##   Expected number of events under H0           : 385.7 
##   Expected number of events under H0/H1        : 371.7 
##   Expected number of events under H1           : 318.3 
##   Number of subjects [1]                       : 973.2 
##   Number of subjects [2]                       : 1000.0 
##   Number of subjects [3]                       : 1000.0 
##   Expected number of subjects under H1         : 995.5 
##   Reject per stage [1]                         : 0.168 
##   Reject per stage [2]                         : 0.372 
##   Reject per stage [3]                         : 0.260 
##   Early stop                                   : 0.54 
##   Critical values (effect scale) [1]           : 0.653 
##   Critical values (effect scale) [2]           : 0.758 
##   Critical values (effect scale) [3]           : 0.815 
##   Local one-sided significance levels [1]      : 0.001525 
##   Local one-sided significance levels [2]      : 0.009162 
##   Local one-sided significance levels [3]      : 0.022000 
## 
## Legend:
##   (i): values of treatment arm i
##   [k]: values at stage k

In addition, the printDesignPlanTable function summarizes the results per stage in a different format and also adds results which are stored in the underlying group-sequential design such as exit probabilities:

## Stage                                       1       2       3       
## Information rate                            0.5     0.75    1       
## Number of events                            193.4   290.1   386.8   
## Analysis time under H1                      23.2    33.3    60      
## Cumulative alpha spent                      0.0015  0.0096  0.025   
## Stage levels                                0.0015  0.0092  0.022   
## Efficacy boundary (Z-value scale)           2.963   2.359   2.014   
## Efficacy boundary (treatment effect scale)  0.653   0.758   0.815

8.1.2 Sample size plots

rpact provides a large number of plots, see the R markdown file “Example: design, sample size and power plots” (provided by rpact) for examples of all plots. Below, we just show two selected plots.

## Source data of the plot:
##   x-axis: sampleSizeResult$eventsPerStage
##   y-axes:
##     y1: sampleSizeResult$criticalValuesEffectScaleUpper[, 1]
##     y2: sampleSizeResult$futilityBoundsEffectScale[, 1]

9 Power calculation

The function getPowerSurvival is the analogue of getSampleSizeSurvival for power calculations and has a very similar syntax. We illustrate its usage for the above example below.

9.1 Example - piece-wise exponential survival, constant accrual intensity, group-sequential design (continued)

What is the power of the trial from the example above if the true hazard ratio is 0.7 rather than the targeted hazard ratio of 0.75 above?

The corresponding power calculation is given below. The function call uses the same arguments as the call to function getSampleSizeSurvival above except that the maximum sample size of 1000 and the maximum number of events of 387 from above are provided as arguments and the hazard ratio is changed to 0.7. In addition, the direction of the test (directionUpper) needs to be specified.

## Design plan parameters and output for survival data:
## 
## Design parameters:
##   Significance level                           : 0.0250 
##   Test                                         : one-sided 
## 
## User defined parameters:
##   Direction upper                              : FALSE 
##   Lambda (2)                                   : 0.025, 0.040, 0.015, 0.010, 0.007 
##   Hazard ratio                                 : 0.700 
##   Maximum number of subjects                   : 1000.0 
##   Maximum number of events                     : 387.0 
##   Accrual time                                 : 23.81 
##   Accrual intensity                            : 42.0 
##   Piecewise survival times                     : 0.00, 6.00, 9.00, 15.00, 21.00 
##   Drop-out rate (1)                            : 0.050 
##   Drop-out rate (2)                            : 0.050 
## 
## Default parameters:
##   Type of computation                          : Schoenfeld 
##   Theta H0                                     : 1 
##   Planned allocation ratio                     : 1 
##   Event time                                   : 12 
##   Drop-out time                                : 12.00 
## 
## Sample size and output:
##   Lambda (1)                                   : 0.0175, 0.0280, 0.0105, 0.0070, 0.0049 
##   Follow up time                               : 39.56 
##   Analysis times [1]                           : 23.58 
##   Analysis times [2]                           : 34.72 
##   Analysis times [3]                           : 63.37 
##   Expected study duration                      : 38.26 
##   Maximal study duration                       : 63.37 
##   Number of events by stage [1]                : 193.5 
##   Number of events by stage [2]                : 290.2 
##   Number of events by stage [3]                : 387.0 
##   Expected number of events                    : 283.6 
##   Number of subjects [1]                       : 990.4 
##   Number of subjects [2]                       : 1000.0 
##   Number of subjects [3]                       : 1000.0 
##   Expected number of subjects                  : 997.0 
##   Reject per stage [1]                         : 0.315 
##   Reject per stage [2]                         : 0.439 
##   Reject per stage [3]                         : 0.181 
##   Overall reject                               : 0.935 
##   Early stop                                   : 0.754 
##   Critical values (effect scale) [1]           : 0.653 
##   Critical values (effect scale) [2]           : 0.758 
##   Critical values (effect scale) [3]           : 0.815 
##   Local one-sided significance levels [1]      : 0.001525 
##   Local one-sided significance levels [2]      : 0.009162 
##   Local one-sided significance levels [3]      : 0.022000 
## 
## Legend:
##   (i): values of treatment arm i
##   [k]: values at stage k

This gives an overall power of 0.94. Note also that the timing of the interim analyses is slightly deferred now (as the events now occur more slowly in the intervention arm) but the expected study duration is decreased from 43.87 to 38.26 months because chances to stop the trial early have increased.

The impact of the true hazard ratio on power and study duration can also be calculated by entering the hazardRatio argument as a vector. Below, the hazard ratio is varied from 0.6 to 1 (in increments of 0.02) and the results are displayed graphically.

For examples of all available plots in rpact, see the R vignette “How to create admirable plots with rpact” (written by rpact, link).

10 Prediction of number of events over time

The function getEventProbabilities calculates the probability that a randomly chosen subject has an observed event up to a specied time after the start of the study. By multiplying this probability with the maximal sample size, we obtain the expected number of events up to that time point.

The arguments for the function getEventProbabilities are similar to those for the function getSampleSizeSurvival discussed above. One difference is that the maximal sample size must always be provided in function getEventProbabilities. This can either be done explicitly by setting argument maxNumberOfSubjects or implicitly by specifying the accrual duration as described in Section @ref(accrualDurationKnown).

For illustration, we revisit the example from Section @ref(sampleSizeGroupSeq). In that example, the sample size was 1000 and the expected timing of the final analysis after observing 387 events was after 60.00 months. The code below re-calculates the expected number of events until that time point.

## Event probabilities at given time:
## 
## User defined parameters:
##   Accrual time                                 : 23.81 
##   Accrual intensity                            : 42.0 
##   Piecewise survival times                     : 0.00, 6.00, 9.00, 15.00, 21.00 
##   Lambda (2)                                   : 0.025, 0.040, 0.015, 0.010, 0.007 
##   Hazard ratio                                 : 0.750 
##   Drop-out rate (1)                            : 0.050 
##   Drop-out rate (2)                            : 0.050 
##   Maximum number of subjects                   : 1000.0 
## 
## Default parameters:
##   Kappa                                        : 1 
##   Planned allocation ratio                     : 1 
##   Drop-out time                                : 12.00 
## 
## Time and output:
##   Time                                         : 60.00 
##   Lambda (1)                                   : 0.01875, 0.03000, 0.01125, 0.00750, 0.00525 
##   Overall event probabilities                  : 0.3868 
##   Event probabilities (1)                      : 0.3444 
##   Event probabilities (2)                      : 0.4292 
## 
## Legend:
##   (i): values of treatment arm i
## [1] 386.7958
## [1] 172.1793
## [1] 214.6165

The function getEventProbabilities also allows a vector argument for time and the code below illustrates how to calculate (and plot) expected event numbers over time (overall and by group). In addition, the number of recruited subjects is added to the plot which can be obtained with function getNumberOfSubjects.